What was the market valuation of the custom antibody market in 2024?

The market valuation was $7.5 Million in 2024. Read More

What is the projected market valuation for the custom antibody market by 2035?

The projected valuation for 2035 is $18.82 Million. Read More

What is the expected CAGR for the custom antibody market during the forecast period 2025 - 2035?

The expected CAGR is 8.72% during the forecast period 2025 - 2035. Read More

Which companies are considered key players in the custom antibody market?

Key players include Thermo Fisher Scientific, Abcam, GenScript, Merck KGaA, Bio-Rad Laboratories, Cell Signaling Technology, Santa Cruz Biotechnology, R&D Systems, and Sigma-Aldrich. Read More

What are the main service segments in the custom antibody market?

Main service segments include Antibody Development, Antibody Production & Purification, and Antibody Fragmentation & Labelling. Read More

What was the market size for Antibody Production & Purification in 2024?

The market size for Antibody Production & Purification was $3.0 Million in 2024. Read More

What is the anticipated growth for the Oncology research area in the custom antibody market by 2035?

The Oncology research area is projected to grow from $1.5 Million in 2024 to $4.5 Million by 2035. Read More

Which type of antibodies is expected to have the highest market size in 2035?

Monoclonal Antibodies are expected to have the highest market size, projected to reach $7.5 Million by 2035. Read More

What is the market size for Academic & Research Institutes as end users in 2024?

The market size for Academic & Research Institutes as end users was $2.0 Million in 2024. Read More

How does the custom antibody market's growth compare across different end user segments?

The growth varies, with Biotechnology Companies projected to grow from $1.5 Million in 2024 to $4.5 Million by 2035, indicating diverse growth potential across segments. Read More

UK Custom Antibody Market

ID: MRFR/HC/51846-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

UK Custom Antibody Market Research Report By Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labelling), By Source (Mice, Others), By Research Area (Oncology, Neurobiology, Infectious Diseases, Immunology, Others), By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibody, Other Custom Antibodies) and By End Users (Hospitals & Clinics, Academic & Research Institute, Contact Research Organization, Biotechnology Companies, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Service (USD Million)
  1. 4.1.1 Antibody Development
  2. 4.1.2 Antibody Production & Purification
  3. 4.1.3 Antibody Fragmentation & Labelling
2. 4.2 Life Sciences, BY Source (USD Million)
  1. 4.2.1 Mice
  2. 4.2.2 Others
3. 4.3 Life Sciences, BY Research Area (USD Million)
  1. 4.3.1 Oncology
  2. 4.3.2 Neurobiology
  3. 4.3.3 Infectious Diseases
  4. 4.3.4 Immunology
  5. 4.3.5 Others
4. 4.4 Life Sciences, BY Type (USD Million)
  1. 4.4.1 Monoclonal Antibodies
  2. 4.4.2 Polyclonal Antibodies
  3. 4.4.3 Recombinant Antibody
  4. 4.4.4 Other Custom Antibodies
5. 4.5 Life Sciences, BY End Users (USD Million)
  1. 4.5.1 Biotechnology Companies
  2. 4.5.2 Hospital & Clinics
  3. 4.5.3 Academic & Research Institutes
  4. 4.5.4 Contract Research Organizations
  5. 4.5.5 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abcam (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 GenScript (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bio-Rad Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cell Signaling Technology (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Santa Cruz Biotechnology (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 R&D Systems (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Sigma-Aldrich (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY SERVICE
3. 6.3 UK MARKET ANALYSIS BY SOURCE
4. 6.4 UK MARKET ANALYSIS BY RESEARCH AREA
5. 6.5 UK MARKET ANALYSIS BY TYPE
6. 6.6 UK MARKET ANALYSIS BY END USERS
7. 6.7 KEY BUYING CRITERIA OF LIFE SCIENCES
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF LIFE SCIENCES
10. 6.10 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
12. 6.12 SUPPLY / VALUE CHAIN: LIFE SCIENCES
13. 6.13 LIFE SCIENCES, BY SERVICE, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY SERVICE, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY SOURCE, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY SOURCE, 2024 TO 2035 (USD Million)
17. 6.17 LIFE SCIENCES, BY RESEARCH AREA, 2024 (% SHARE)
18. 6.18 LIFE SCIENCES, BY RESEARCH AREA, 2024 TO 2035 (USD Million)
19. 6.19 LIFE SCIENCES, BY TYPE, 2024 (% SHARE)
20. 6.20 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million)
21. 6.21 LIFE SCIENCES, BY END USERS, 2024 (% SHARE)
22. 6.22 LIFE SCIENCES, BY END USERS, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE, 2025-2035 (USD Million)
  2. 7.2.2 BY SOURCE, 2025-2035 (USD Million)
  3. 7.2.3 BY RESEARCH AREA, 2025-2035 (USD Million)
  4. 7.2.4 BY TYPE, 2025-2035 (USD Million)
  5. 7.2.5 BY END USERS, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Life Sciences Market Segmentation

Life Sciences By Service (USD Million, 2025-2035)

Antibody Development
Antibody Production & Purification
Antibody Fragmentation & Labelling

Life Sciences By Source (USD Million, 2025-2035)

Mice
Others

Life Sciences By Research Area (USD Million, 2025-2035)

Oncology
Neurobiology
Infectious Diseases
Immunology
Others

Life Sciences By Type (USD Million, 2025-2035)

Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibody
Other Custom Antibodies

Life Sciences By End Users (USD Million, 2025-2035)

Biotechnology Companies
Hospital & Clinics
Academic & Research Institutes
Contract Research Organizations
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”